Infinimmune vs ParcelBio
Infinimmune vs ParcelBio, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Infinimmune is on 60/100 and ParcelBio on 52/100.
Where each one leads
Infinimmune
- our overall score: 60/100 against 52/100
- agent readiness: 42/100 against 33/100
- domain rating: 20/100 against 17/100
- headcount: 22 against 6
- LinkedIn following: 4,055 against 1,243
ParcelBio
- funding raised: $100M against $75.0M
At a glance
| Measure | Infinimmune | ParcelBio |
|---|---|---|
| What it is | Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms. | Advancing next-generation mRNA medicines. |
| Category | Biotechnology, Pharmaceuticals, Artificial Intelligence, HealthTech | Biotechnology, Pharmaceuticals, HealthTech, Artificial Intelligence |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2023 |
| Headquarters | Alameda, United States | San Francisco, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Infinimmune | ParcelBio |
|---|---|---|
| Employees | 22 | 6 |
| Total funding | $75.0M | $100M |
| Latest round | Series A | Series A |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 4,055 | 1,243 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Infinimmune | ParcelBio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 52/100 |
| Traction | 53/100 | 48/100 |
| Team | 70/100 | Not published |
| Search visibility | 23/100 | 33/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (33/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 17/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Infinimmune | ParcelBio |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Webflow | Webflow |
| Analytics | Google Analytics 4 | Not detected |
Infinimmune vs ParcelBio: common questions
Which is better, Infinimmune or ParcelBio?
On our 0-100 score Infinimmune rates higher (60/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Infinimmune and ParcelBio compare on the numbers?
Infinimmune leads on our overall score (60/100 against 52/100), agent readiness (42/100 against 33/100), domain rating (20/100 against 17/100), headcount (22 against 6), LinkedIn following (4,055 against 1,243). ParcelBio leads on funding raised ($100M against $75.0M).
Read the full Infinimmune review and pricing or the ParcelBio review and pricing. You can also browse other Infinimmune alternatives we track.